TC
SGFY

Trium Capital’s Signify Health, Inc. SGFY Stock Holding History

Trium Capital’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-232,530
Closed -$6.66M – 91
2022
Q4 		$6.66M Buy
+232,530
New +$6.71M 2.45% 11

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Trium Capital's SGFY Position: Q1 2023 in Review

Trium Capital sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 232,530 shares — an estimated $6.66M sold.

Trium Capital first reported a position in SGFY in Q4 2022 and held it in 1 quarter. The position peaked at $6.66M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Trium Capital reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Trium Capital sold 232,530 Signify Health, Inc. shares in Q1 2023, an estimated $6.66M.
  • Trium Capital first reported a position in Signify Health, Inc. in Q4 2022 and held it in 1 quarter.
  • Trium Capital's Signify Health, Inc. position peaked at $6.66M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Trium Capital's 13F filing for Q1 2023, filed 16 May 2023.